You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
You are here
Carlos L. Arteaga, MD
Research & Funding Opportunities
Stand Up To Cancer Canada (SU2C Canada)
Current Funding Opportunity
Canadian Scientific Advisory Committee
About the Breast Cancer Dream Team
About the Cancer Stem Cell Dream Team
Carlos L. Arteaga, MD
Dr. Arteaga is the Director of the Harold C. Simmons Comprehensive Cancer Center at the University of Texas Southwestern Medical Center. He is also the Associate Dean of Oncology Programs. An international leader in the field of breast cancer research, Dr. Arteaga has contributed to the understanding of breast cancer initiation, progression, and metastasis by identifying and characterizing key molecular pathways dysregulated in this disease. He was the first to report the role of IGF-I receptors and transforming growth factor β (TGF-β) in breast cancer and their use as therapeutic targets. He demonstrated that TGF-β, in addition to contributing to breast carcinogenesis, is also capable of driving epithelial to mesenchymal transition, establishment of metastasis, expansion of cancer stem cells, and resistance to chemotherapy. These observations have been significant for the development of molecularly targeted drugs designed to inhibit these signaling pathways. He also reported one of the first studies describing the synergistic effect of chemotherapy with anti-HER2 antibodies, a finding that contributed to the clinical development of trastuzumab for the treatment of patients with HER2-overexpressing breast cancer.
Dr. Arteaga earned his medical degree from the Universidad de Guayaquil in Ecuador. He trained at the Emory University School of Medicine and at the University of Texas Health Science Center at San Antonio. He served for many years at the Vanderbilt-Ingram Cancer Center, where he led a successful translational research program, including an NCI/NIH SPORE in breast cancer. He has received many awards from the American Cancer Society, AACR, the Susan G. Komen for the Cure Foundation, and the American Society of Clinical Oncology. Dr. Arteaga served as the AACR president in 2014-2015.
© American Association for Cancer Research International-Canada | c/o TMF Canada Management Inc. |
330 Bay Street, Suite 280 | Toronto, Ontario, Canada M5H 2S8 | Telephone: 647-794-4598